|
Q4 2021
Filed on Feb 14, 2022
|
49,577
|
$8.38 - $9.95
$415K - $493K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
13,401
|
$5.68 - $7.85
$76.1K - $105K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
11,360
|
$8.05 - $9.12
$91.4K - $104K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
4,212
|
$75.75 - $94.38
$319K - $398K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
17,677
|
$4.43 - $5.62
$78.3K - $99.3K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
5,147
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
27,290
|
$5.41 - $8.5
$148K - $232K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
15,639
|
$18.55 - $21.25
$290K - $332K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
11,217
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
11,029
|
$10.22 - $16.68
$113K - $184K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
3,174
|
$69.09 - $79.85
$219K - $253K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
10,843
|
$5.92 - $9.31
$64.2K - $101K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
1,091
|
$394.21 - $439.01
$430K - $479K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
11,367
|
$1.07 - $3.46
$12.2K - $39.3K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
18,543
|
$5.47 - $7.03
$101K - $130K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,853
|
$120.37 - $150.62
$343K - $430K
|
|
Churchill Capital Corp Iv
|
Q3 2021
Filed on Nov 15, 2021
|
25,506
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
11,085
|
$19.68 - $22.51
$218K - $250K
|
|
Western Asset Mtg Cap Corp
|
Q3 2021
Filed on Nov 15, 2021
|
15,649
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
17,692
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
71,472
|
$3.61 - $5.0
$258K - $357K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,342
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
10,905
|
$58.38 - $84.96
$637K - $926K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
11,314
|
N/A
|
|
New Oriental Ed & Technology
|
Q3 2021
Filed on Nov 15, 2021
|
289,636
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
3,716
|
$110.2 - $156.64
$410K - $582K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
22,183
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
5,140
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,667
|
$161.38 - $258.6
$269K - $431K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,819
|
$132.13 - $177.45
$372K - $500K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
14,852
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
35,994
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
8,494
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,536
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
28,773
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
3,680
|
$55.43 - $59.79
$204K - $220K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
4,063
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
22,673
|
N/A
|
|
Calithera Biosciences Inc
|
Q3 2021
Filed on Nov 15, 2021
|
16,387
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
16,246
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
11,966
|
$2.5 - $3.53
$29.9K - $42.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
10,043
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
20,467
|
$1.01 - $1.82
$20.7K - $37.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
18,815
|
N/A
|
|
Minerva Neurosciences Inc
|
Q3 2021
Filed on Nov 15, 2021
|
10,126
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
12,605
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
10,391
|
$1.3 - $2.23
$13.5K - $23.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
4,566
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 15, 2021
|
10,867
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
13,197
|
N/A
|
|